{
  "schema": "https://data.sciveyor.com/schema",
  "version": 5,
  "id": "doi:10.1371/journal.pbio.0030061",
  "doi": "10.1371/journal.pbio.0030061",
  "license": "This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",
  "licenseUrl": "https://creativecommons.org/licenses/by/4.0/",
  "dataSource": "Public Library of Science",
  "dataSourceUrl": "https://data.sciveyor.com/source/plos",
  "dataSourceVersion": 1,
  "type": "article",
  "title": "Correction: Regulation of Muscle Fiber Type and Running Endurance by PPARδ",
  "journal": "PLoS Biology",
  "date": "2005-01",
  "dateElectronic": "2005-01-18",
  "volume": "3",
  "number": "1",
  "pages": "e61",
  "tags": [
    "Discipline/Biotechnology",
    "Discipline/Biotechnology/Bioengineering",
    "Discipline/Cell Biology",
    "Discipline/Developmental Biology",
    "Discipline/Molecular Biology",
    "Discipline/Physiology",
    "System Taxonomy/Mus (mouse)",
    "Type/Correction"
  ],
  "fullText": "In PLoS Biology, volume 2, issue 10:\n\nRegulation of Muscle Fiber Type and Running Endurance by PPARδ.\n\n        Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, et al.\n\n        10.1371/journal.pbio.0020294\n\nThe following competing interest should have been indicated in the above research article. R. M. Evans wishes to acknowledge a consulting relationship with Ligand Pharmaceuticals. Under a licensing agreement with GlaxoSmithKline, Ligand receives milestone payments on the development of GW501516, a PPARδ-specific drug used in this study. For clarification, no materials or support were received from either company, and no agreements were in place concerning the execution or publication of this work.\n\nPublished January 18, 2005"
}